Filgrastim April 12, 2017 Filgrastim Trade Name Neupogen Orphan Indication Myelodysplastic syndrome USA Market Approval USA USA Designation Date 1990-08-30 00:00:00 Sponsor Amgen, Inc.;1840 Dehavilland Drive;Thousand Oaks, California, 91320
